Metlife

MET-N

NYSE:MET

49.50
0.57 (1.16%)
MetLife, Inc. is the holding corporation for the Metropolitan Life Insurance Company, better known as MetLife, and its affiliates.
More at Wikipedia

Analysis and Opinions about MET-N

Signal
Opinion
Expert
BUY
BUY
September 20, 2019
It’s pretty cheap, trading at 8.1 times. Their earnings in July were double year over year and beat expectations. They are growing globally and it’s a safe name with a low valuation. Couldn’t go wrong with this choice in the long term.
Metlife (MET-N)
September 20, 2019
It’s pretty cheap, trading at 8.1 times. Their earnings in July were double year over year and beat expectations. They are growing globally and it’s a safe name with a low valuation. Couldn’t go wrong with this choice in the long term.
Greg Newman
Director & Portfolio Manager, Scotia Wealth Management
Price
$47.440
Owned
Unknown
WAIT
WAIT
August 8, 2019
MET vs. BAC. Dynamics of the two are different, so hard to compare. FMV potential of both is huge. But the market won't go, because interest rates are falling. Aren't any drivers to escalate earnings. Very cheap, but who knows when they're going to pop? (Analysts’ price target is $53.19)
Metlife (MET-N)
August 8, 2019
MET vs. BAC. Dynamics of the two are different, so hard to compare. FMV potential of both is huge. But the market won't go, because interest rates are falling. Aren't any drivers to escalate earnings. Very cheap, but who knows when they're going to pop? (Analysts’ price target is $53.19)
Ross Healy
Chairman, Strategic Analysis Corp
Price
$47.170
Owned
Unknown
DON'T BUY
DON'T BUY
June 14, 2019
The balance sheet is impaired and there should be write-offs, which he hasn't seen. He sees 32% upside with a $64 model price, but he'd be happy seeing this at $53.80. He would recommend this stock above this price. He has recommended MET before, but MET just can't get going. The balance sheet is ugly. Also, if interest rates fall to zero, all insurance companies will get hit.
Metlife (MET-N)
June 14, 2019
The balance sheet is impaired and there should be write-offs, which he hasn't seen. He sees 32% upside with a $64 model price, but he'd be happy seeing this at $53.80. He would recommend this stock above this price. He has recommended MET before, but MET just can't get going. The balance sheet is ugly. Also, if interest rates fall to zero, all insurance companies will get hit.
Brian Acker, CA
Chief Executive Officer, President and Chief Inves, Acker Finley Inc.
Price
$48.810
Owned
Yes
PAST TOP PICK
PAST TOP PICK
March 18, 2019
(A Top Pick Mar 29/18, Up 3%) Slow or flar growth this and next year, but they are buying back stock. He sees 9% EPS growth this year. Their US retirement portfolio has been doing well. It's cheap at 8x PE and paying almost a 4% dividend. It's been stagnant for many years, but it has tailwinds of lower taxes and volume growth. They're growing in Asia and Europe.
Metlife (MET-N)
March 18, 2019
(A Top Pick Mar 29/18, Up 3%) Slow or flar growth this and next year, but they are buying back stock. He sees 9% EPS growth this year. Their US retirement portfolio has been doing well. It's cheap at 8x PE and paying almost a 4% dividend. It's been stagnant for many years, but it has tailwinds of lower taxes and volume growth. They're growing in Asia and Europe.
Greg Newman
Director & Portfolio Manager, Scotia Wealth Management
Price
$45.750
Owned
Yes
DON'T BUY
DON'T BUY
March 6, 2019
Metlife vs. Prudential vs US banks Both are high quality and international. Strong. He doesn't love lifecos now, because there's a lot going on in health, such as the prevalance of diabetes. He wants to see higher interest rates which can benefit lifecos. As for banks, he'd stay away. The rates and yield curve have flattened. Met are doing the right thing, like a nice dividend and a big share buybacks. It isn't expensive and doing 10% earnings growth, but there are greener pastures elsewhere.
Metlife (MET-N)
March 6, 2019
Metlife vs. Prudential vs US banks Both are high quality and international. Strong. He doesn't love lifecos now, because there's a lot going on in health, such as the prevalance of diabetes. He wants to see higher interest rates which can benefit lifecos. As for banks, he'd stay away. The rates and yield curve have flattened. Met are doing the right thing, like a nice dividend and a big share buybacks. It isn't expensive and doing 10% earnings growth, but there are greener pastures elsewhere.
Cameron Hurst
Chief Investment Officer, Equium Capital Management
Price
$44.320
Owned
Unknown
COMMENT
COMMENT
February 8, 2019
Insurance companies are trading below their lower benchmarks -- making him think there are issues with their balance sheets especially in a deflationary recession environment. This could lead to lower short term rates, which could impair their earnings. He would be cautious going forward for all insurance companies.
Metlife (MET-N)
February 8, 2019
Insurance companies are trading below their lower benchmarks -- making him think there are issues with their balance sheets especially in a deflationary recession environment. This could lead to lower short term rates, which could impair their earnings. He would be cautious going forward for all insurance companies.
Brian Acker, CA
Chief Executive Officer, President and Chief Inves, Acker Finley Inc.
Price
$42.710
Owned
Unknown
DON'T BUY
DON'T BUY
December 10, 2018
SLF-T vs. MET-N. He prefers Sunlife (SLF-T). It is higher quality and more defensive. Also they are down with the sector. There is more competition in the US vs. Canada.
Metlife (MET-N)
December 10, 2018
SLF-T vs. MET-N. He prefers Sunlife (SLF-T). It is higher quality and more defensive. Also they are down with the sector. There is more competition in the US vs. Canada.
Teal Linde
Portfolio Manager & Publisher, Linde Equity Report, Linde Equity Report
Price
$39.610
Owned
Unknown
PAST TOP PICK
PAST TOP PICK
July 17, 2018

(A Top Pick July 11, 2017. Down 7%). This has gone down even as interest rates have come up. He is holding with it, with a very small position. Life insurers are not participating in the financials rally as much as he expected. His model price shows a 47% upside, but the market appears to dislike some aspect of MetLife’s balance sheet and he is not sure what that is. Because he is not sure what is wrong, he would not buy it.

Metlife (MET-N)
July 17, 2018

(A Top Pick July 11, 2017. Down 7%). This has gone down even as interest rates have come up. He is holding with it, with a very small position. Life insurers are not participating in the financials rally as much as he expected. His model price shows a 47% upside, but the market appears to dislike some aspect of MetLife’s balance sheet and he is not sure what that is. Because he is not sure what is wrong, he would not buy it.

Brian Acker, CA
Chief Executive Officer, President and Chief Inves, Acker Finley Inc.
Price
$44.190
Owned
Yes
COMMENT
COMMENT
May 29, 2018

One of the biggest life insurance companies. Spawned off the individual insurance part in a company called Brighthouse earlier this year. MetLife has been hurt lately by some controversy. In the long run still likes the outlook for both Brighthouse and Metlife, and rising interests rate do help insurance companies a lot.

Metlife (MET-N)
May 29, 2018

One of the biggest life insurance companies. Spawned off the individual insurance part in a company called Brighthouse earlier this year. MetLife has been hurt lately by some controversy. In the long run still likes the outlook for both Brighthouse and Metlife, and rising interests rate do help insurance companies a lot.

Norman Levine
Managing Director, Portfolio Management Corp
Price
$45.160
Owned
Unknown
PAST TOP PICK
PAST TOP PICK
April 25, 2018

(A Top Pick July 11/17 Down 2%) All the insurers are being helped by rising interest rates, yet the stock price has not increased. He is disappointed by the performance, but will continue to stick with it. He has a model price about 30% higher. Yield 3.5%.

Metlife (MET-N)
April 25, 2018

(A Top Pick July 11/17 Down 2%) All the insurers are being helped by rising interest rates, yet the stock price has not increased. He is disappointed by the performance, but will continue to stick with it. He has a model price about 30% higher. Yield 3.5%.

Brian Acker, CA
Chief Executive Officer, President and Chief Inves, Acker Finley Inc.
Price
$47.830
Owned
Yes
PAST TOP PICK
PAST TOP PICK
April 19, 2018

(A Top Pick May 1/17, Up 5%) It spun out Bright House. He continues to own both. They had to take a hit on benefits that people were not getting and should have.

Metlife (MET-N)
April 19, 2018

(A Top Pick May 1/17, Up 5%) It spun out Bright House. He continues to own both. They had to take a hit on benefits that people were not getting and should have.

Norman Levine
Managing Director, Portfolio Management Corp
Price
$47.440
Owned
Yes
DON'T BUY
DON'T BUY
April 11, 2018

This is a diversified insurance company with a bias to life. It is in a good capital situation. The technical chart is too boom and bust, which he can’t explain. Insurance broadly has generally under-performed and he thinks you are taking more risk than the reward you are getting. He would prefer straight financial stocks instead.

Metlife (MET-N)
April 11, 2018

This is a diversified insurance company with a bias to life. It is in a good capital situation. The technical chart is too boom and bust, which he can’t explain. Insurance broadly has generally under-performed and he thinks you are taking more risk than the reward you are getting. He would prefer straight financial stocks instead.

Cameron Hurst
Chief Investment Officer, Equium Capital Management
Price
$46.050
Owned
No
TOP PICK
TOP PICK
March 29, 2018

A sleepy little story. It is really cheap. He likes it for strong buybacks, dividend growth and upping their return on equity. 11% forecast earnings growth. (Analysts’ target: $55.00).

Metlife (MET-N)
March 29, 2018

A sleepy little story. It is really cheap. He likes it for strong buybacks, dividend growth and upping their return on equity. 11% forecast earnings growth. (Analysts’ target: $55.00).

Greg Newman
Director & Portfolio Manager, Scotia Wealth Management
Price
$45.890
Owned
Yes
PAST TOP PICK
PAST TOP PICK
January 25, 2018

(A Top Pick Jan 13/17. Up 15%.) Still likes this. It’s trading at about 1X Price to Book, which is cheap in the financial world. Pays about a 3% dividend, which is expected to grow 6%-7% over the next several years. Right now, the 10-year treasury is above 260 and rising interest rates will help companies like this. They have very strong international operations. 3% dividend yield.

Metlife (MET-N)
January 25, 2018

(A Top Pick Jan 13/17. Up 15%.) Still likes this. It’s trading at about 1X Price to Book, which is cheap in the financial world. Pays about a 3% dividend, which is expected to grow 6%-7% over the next several years. Right now, the 10-year treasury is above 260 and rising interest rates will help companies like this. They have very strong international operations. 3% dividend yield.

Stan Wong
Director & Portfolio Manager, Private Wealth Management, ScotiaMcleod
Price
$54.000
Owned
Yes
PAST TOP PICK
PAST TOP PICK
January 19, 2018

(A Top Pick May 8/17. Up 15%.) Changes to the US are positive in one sense, but there are problems in the insurance industry in another. Interest rates are going up, which should help. He would probably hang in, with the admonition that if something better came along, he might jump.

Metlife (MET-N)
January 19, 2018

(A Top Pick May 8/17. Up 15%.) Changes to the US are positive in one sense, but there are problems in the insurance industry in another. Interest rates are going up, which should help. He would probably hang in, with the admonition that if something better came along, he might jump.

Ross Healy
Chairman, Strategic Analysis Corp
Price
$53.400
Owned
Yes
Showing 1 to 15 of 100 entries